Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01736111 · ClinicalTrials.gov registry record · NA

Text Messaging for Weight Loss

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
91
Enrollment target

NCT01736111: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.

NCT01736111 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01736111, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target

Study Summary

Overweight and obese adults recruited from the primary care setting (n=150) will be enrolled in a 6-month randomized trial of the INTERVENTION versus CONTROL. Both groups will receive usual medical care, printed materials, and educational text messages. The INTERVENTION group will also receive personalized coaching and feedback, as well as peer support, via text message. The investigators hypothesize that compared to those in the Control group, patients in the Intervention group will lose more weight and demonstrate more favorable changes in fruit and vegetable intake, exercise, and social support for weight loss.

Primary Outcome

Weight in a lightweight hospital gown with no shoes (calibrated digital scale)

Interventions

  • BEHAVIORAL one way text
  • BEHAVIORAL Personal feedback

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2012-10
Est. Completion 2015-03
Phase NA

What the finished NCT01736111 record still lists

NCT01736111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which one way text is the first listed.

NCT01736111 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01736111 about?

NCT01736111 is a clinical study titled "Text Messaging for Weight Loss". Overweight and obese adults recruited from the primary care setting (n=150) will be enrolled in a 6-month randomized trial of the INTERVENTION versus CONTROL. Both groups will receive usual medical care, printed materials, and educational text messages. The INTERVENTION group will also receive perso...

What is the current status of trial NCT01736111?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2012-10. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01736111?

The interventions under investigation include: one way text (BEHAVIORAL), Personal feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT01736111?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01736111's enrollment target sits among peer trials

91 939th of 2000 higher than 1,060 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02671448 · 91 participants · NA

    Pilot Trial of Homebound Stem Cell Transplantation

  • NCT04835857 · 91 participants

    Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

  • NCT05184842 · 91 participants · Phase 2

    Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • NCT05685173 · 91 participants · Phase 1

    A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01736111, the US trial registry maintained by the National Library of Medicine. NCT01736111 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.